Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 22;70(3):e20231260.
doi: 10.1590/1806-9282.20231260. eCollection 2024.

Biological action of melatonin on target receptors in breast cancer

Paulo Celso Pardi  1 , José Antonio Orellana Turri  1 , Luiza Helena Costa Moreira Bayer  1 , Gabriela Bezerra Nóbrega  2 , José Roberto Filassi  2 , Ricardo Dos Santos Simões  1 , Bruna Salani Mota  2 , Isabel Cristina Espósito Sorpreso  1 , Edmund Chada Baracat  1 , José Maria Soares Júnior  1
Affiliations
Review

Biological action of melatonin on target receptors in breast cancer

Paulo Celso Pardi et al. Rev Assoc Med Bras (1992). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: the authors declare there is no conflicts of interest.

References

    1. Ahmad SB, Ali A, Bilal M, Rashid SM, Wani AB, Bhat RR, et al. Melatonin and health: insights of melatonin action, biological functions, and associated disorders. Cell Mol Neurobiol. 2023;43(6):2437–2458. doi: 10.1007/s10571-023-01324-w. - DOI - PMC - PubMed
    1. Bhattacharya S, Patel KK, Dehari D, Agrawal AK, Singh S. Melatonin and its ubiquitous anticancer effects. Mol Cell Biochem. 2019;462(1-2):133–155. doi: 10.1007/s11010-019-03617-5. - DOI - PubMed
    1. Amin N, Shafabakhsh R, Reiter RJ, Asemi Z. Melatonin is an appropriate candidate for breast cancer treatment: based on known molecular mechanisms. J Cell Biochem. 2019;120(8):12208–15. doi: 10.1002/jcb.28832. - DOI - PubMed
    1. Shim S, Park KM, Chung YJ, Kim MR. Updates on therapeutic alternatives for genitourinary syndrome of menopause: hormonal and non-hormonal managements. J Menopausal Med. 2021;27(1):1–7. doi: 10.6118/jmm.20034. - DOI - PMC - PubMed
    1. Veiga ECA, Simões R, Valenti VE, Cipolla-Neto J, Abreu LC, Barros EPM, et al. Repercussions of melatonin on the risk of breast cancer: a systematic review and meta-analysis. Rev Assoc Med Bras (1992) 2019;65(5):699–705. doi: 10.1590/1806-9282.65.5.699. - DOI - PubMed